CCR5 antagonist maraviroc alleviates doxorubicin-induced neuroinflammation and neurobehavioral deficiency by regulating NF-κB/NLRP3 signaling in a breast cancer mouse model

Authors:

Abstract
No abstract available
Funding Information
  • National Natural Science Foundation of China
  • Science and Technology Commission of Shanghai Municipality

This publication has 56 references indexed in Scilit: